Search - tctmd.com

Displaying 141 - 160 of 830

Sort: Relevancy | Date

Presentation AHA 2023

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

Presenter: Alexander C. Fanaroff

November 13, 2023

News Conference News AHA 2023

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

Shelley Wood

November 13, 2023

News Conference News AHA 2023

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

Caitlin E. Cox

November 12, 2023

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

Presentation AHA 2023

Safety and Pharmacodynamic Effects of VERVE-101

Presenter: Andrew Bellinger

November 11, 2023

Presentation AHA 2023

Lepodisiran: An Extended-Duration siRNA Targeting Lipoprotein(a)

Presenter: Steven E. Nissen

November 11, 2023

News Conference News AHA 2023

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

Caitlin E. Cox

November 07, 2023

News Daily News

Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow

Michael O'Riordan

November 02, 2023

Presentation TCT 2023

TCT 461: Suboptimal Lipid Lowering Treatment After Complex PCI in Contemporary Practice

Presenter: Denise Peeters

October 25, 2023

Presentation TCT 2023

TCT 271: Characterizing pathophysiological patterns of coronary artery disease among Individuals with Elevated Lipoprotein(a).

Presenter: Mick Renkens

October 25, 2023

Presentation TCT 2023

TCT 249: Remnant Cholesterol as a Residual Risk in Patients with Atherosclerotic Cardiovascular Disease under Moderate-intensity Statin with Ezetimibe Combination Therapy or High-intensity Statin Monotherapy

Presenter: Jung-Hee Lee

October 25, 2023

Presentation TCT 2023

TCT 160: Comparative Effectiveness of Moderate-intensity Statin with Ezetimibe Combination Therapy Versus High-intensity Statin Monotherapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study

Presenter: Ji-Yong Jang

October 25, 2023

TCT 50: Statin and Ezetimibe Combination Therapy Versus Statin Monotherapy for Cardiovascular Outcomes Among Patients Undergoing PCI

Presentation TCT 2023

TCT 50: Statin and Ezetimibe Combination Therapy Versus Statin Monotherapy for Cardiovascular Outcomes Among Patients Undergoing Percutaneous Coronary Intervention: A Nationwide, Retrospective, Population-based Study Using National Health Insurance Data…

Presenter: Young-Hoon Seo

October 25, 2023

Presentation TCT 2023

TCT 628: The Impact of Long-term Exposure to Air Pollution on Plaque Characteristics Assessed by Intravascular Optical Coherence Tomography

Presenter: Juhwan Lee

October 25, 2023

Presentation TCT 2023

TCT 555: NIRS-Detected Lipid-Rich Plaques are Highly Responsive to Novel Escalated LDL-C Reduction Therapy

Presenter: Karlis Trusinskis

October 25, 2023

Presentation TCT 2023

TCT 379: Impact of the Residual Lipid Burden on the Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention

Presenter: Woohyeun Kim

October 25, 2023

Presentation TCT 2023

TCT 252: NIRS-IVUS assessment of OCT-derived Healed Coronary Plaques

Presenter: Kosei Terada

October 25, 2023

Presentation TCT 2023

TCT 235: Patterns of High-Risk Endothelial Shear Stress and Endothelial Shear Stress Gradients in Plaques with Abnormal vs Normal Resting Fractional Flow Reserve Ratio

Presenter: Diaa Hakim

October 25, 2023

Presentation TCT 2023

TCT 161: Coronary Lipid Burden Early After Heart Transplantation as Assessed by Optical Coherence Tomography (OCT)

Presenter: Daneyal Syed

October 25, 2023

Presentation TCT 2023

TCT 116: Clinical Outcomes of AMI Arising from Non-lipid-rich Plaque determined by NIRS-IVUS

Presenter: Kosei Terada

October 25, 2023

Advertisement

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Safety and Pharmacodynamic Effects of VERVE-101

Lepodisiran: An Extended-Duration siRNA Targeting Lipoprotein(a)

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow

TCT 461: Suboptimal Lipid Lowering Treatment After Complex PCI in Contemporary Practice

TCT 271: Characterizing pathophysiological patterns of coronary artery disease among Individuals with Elevated Lipoprotein(a).

TCT 249: Remnant Cholesterol as a Residual Risk in Patients with Atherosclerotic Cardiovascular Disease under Moderate-intensity Statin with Ezetimibe Combination Therapy or High-intensity Statin Monotherapy

TCT 160: Comparative Effectiveness of Moderate-intensity Statin with Ezetimibe Combination Therapy Versus High-intensity Statin Monotherapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study

TCT 50: Statin and Ezetimibe Combination Therapy Versus Statin Monotherapy for Cardiovascular Outcomes Among Patients Undergoing Percutaneous Coronary Intervention: A Nationwide, Retrospective, Population-based Study Using National Health Insurance Data…

TCT 628: The Impact of Long-term Exposure to Air Pollution on Plaque Characteristics Assessed by Intravascular Optical Coherence Tomography

TCT 555: NIRS-Detected Lipid-Rich Plaques are Highly Responsive to Novel Escalated LDL-C Reduction Therapy

TCT 379: Impact of the Residual Lipid Burden on the Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention

TCT 252: NIRS-IVUS assessment of OCT-derived Healed Coronary Plaques

TCT 235: Patterns of High-Risk Endothelial Shear Stress and Endothelial Shear Stress Gradients in Plaques with Abnormal vs Normal Resting Fractional Flow Reserve Ratio

TCT 161: Coronary Lipid Burden Early After Heart Transplantation as Assessed by Optical Coherence Tomography (OCT)

TCT 116: Clinical Outcomes of AMI Arising from Non-lipid-rich Plaque determined by NIRS-IVUS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content